Cargando…

Patients with atrial fibrillation and permanent pacemaker: Temporal changes in patient characteristics and pharmacotherapy

BACKGROUND: The management of patients with non-valvular atrial fibrillation (NVAF) with rate-lowering or anti-arrhythmic drugs has markedly changed over the last decade, but it is unknown how these changes have affected patients with NVAF with a permanent pacemaker (PPM). METHODS: Through Danish na...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalgaard, Frederik, Ruwald, Martin H., Lindhardt, Tommi Bo, Gislason, Gunnar H., Torp-Pedersen, Christian, Pallisgaard, Jannik L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874078/ https://www.ncbi.nlm.nih.gov/pubmed/29590209 http://dx.doi.org/10.1371/journal.pone.0195175

Ejemplares similares

Risk factors and a 3-month risk score for predicting pacemaker implantation in patients with atrial fibrillation
por: Dalgaard, Frederik, et al.
Publicado: (2020)

GARFIELD-AF model for prediction of stroke and major bleeding in atrial fibrillation: a Danish nationwide validation study
por: Dalgaard, Frederik, et al.
Publicado: (2019)

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
por: Staerk, Laila, et al.
Publicado: (2015)

Treatment patterns for oral anticoagulants in older patients with atrial fibrillation: a retrospective, cross-sectional, nationwide study from Denmark
por: Rasmussen, Peter Vibe, et al.
Publicado: (2022)

Risk of Ischemic Stroke, Hemorrhagic Stroke, Bleeding, and Death in Patients Switching from Vitamin K Antagonist to Dabigatran after an Ablation
por: Pallisgaard, Jannik Langtved, et al.
Publicado: (2016)

Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in Denmark
por: Staerk, Laila, et al.
Publicado: (2016)

Atrial Fibrillation in Patients with Permanent VVI Pacemakers: Risk Factors for Atrial Fibrillation
por: Cho, Jeong Gwan, et al.
Publicado: (1997)

Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study
por: Pallisgaard, Jannik Langtved, et al.
Publicado: (2015)

Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines‐Atrial Fibrillation
por: Dalgaard, Frederik, et al.
Publicado: (2020)

Atrial fibrillation onset before heart failure or vice versa: what is worst? A nationwide register study
por: Pallisgaard, Jannik, et al.
Publicado: (2022)

Catheter ablation and mortality, stroke and heart failure readmission with atrial fibrillation
por: Pallisgaard, Jannik Langtved, et al.
Publicado: (2020)

Risk of post-discharge fall-related injuries among adult patients with syncope: A nationwide cohort study
por: Numé, Anna-Karin, et al.
Publicado: (2018)

Short- and long-term risk of atrial fibrillation recurrence after first time ablation according to body mass index: a nationwide Danish cohort study
por: Tønnesen, Jacob, et al.
Publicado: (2022)

Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus
por: Jørgensen, Casper H, et al.
Publicado: (2014)

Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study
por: Sindet-Pedersen, Caroline, et al.
Publicado: (2017)

Incidence of new onset atrial fibrillation in patients with permanent pacemakers and the relation to the pacing mode
por: Said, Sarmad, et al.
Publicado: (2014)

Risk and timing of venous thromboembolism in patients with gastrointestinal cancer: a nationwide Danish cohort study
por: Tønnesen, Jacob, et al.
Publicado: (2023)

Pharmacotherapy of atrial fibrillation in COVID-19 patients
por: Tomaszuk-Kazberuk, Anna, et al.
Publicado: (2021)

Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation
por: Liu, Zhijie, et al.
Publicado: (2023)

Ischemic Stroke Severity and Mortality in Patients With and Without Atrial Fibrillation
por: Vinding, Naja E., et al.
Publicado: (2022)

5 years incident stroke, heart failure, acute myocardial infarction, and death in patients having undergone atrial fibrillation ablation according to BMI
por: Toennesen, J, et al.
Publicado: (2023)

Genetic background of sinus node dysfunction requiring permanent pacemaker implantation after atrial fibrillation catheter ablation
por: Park, J W, et al.
Publicado: (2023)

Permanent Pacemaker Implantations after Catheter Ablation in Patients with Atrial Fibrillation Associated with Underlying Sinus Node Dysfunction
por: Hwang, Tae Hyun, et al.
Publicado: (2019)

Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide Cohort
por: Gundlund, Anna, et al.
Publicado: (2018)

Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study
por: Christiansen, Christine Benn, et al.
Publicado: (2013)

Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study
por: Christiansen, Christine Benn, et al.
Publicado: (2018)

Recent advances in pharmacotherapy of atrial fibrillation
por: Singh, J., et al.
Publicado: (2009)

Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark
por: Rasmussen, Peter Vibe, et al.
Publicado: (2020)

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
por: Sørensen, Rikke, et al.
Publicado: (2013)

Anticoagulation Management in Patients with Pacemaker-Detected Atrial Fibrillation
por: Poposka, Lidija, et al.
Publicado: (2016)

Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study
por: Jakobsen, Christina Boegh, et al.
Publicado: (2019)

Trends in warfarin use and its associations with thromboembolic and bleeding rates in a population with atrial fibrillation between 1996 and 2011
por: Hansen, Peter Wæde, et al.
Publicado: (2018)

Atrial High-Rate Event Incidence and Predictors in Patients With Permanent Pacemaker Implantation
por: Chen, Jian Hua, et al.
Publicado: (2021)

Early Versus Late Catheter Ablation of Atrial Fibrillation and Risk of Permanent Pacemaker Implantation in Patients With Underlying Sinus Node Dysfunction
por: Butt, Muhammad Umer, et al.
Publicado: (2022)

Prognostic importance of atrial fibrillation in heart failure according to time elapsed since diagnosis
por: Schwartz, Brian, et al.
Publicado: (2022)

Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study
por: Lindhardsen, Jesper, et al.
Publicado: (2012)

Familial Clustering of Venous Thromboembolism – A Danish Nationwide Cohort Study
por: Sindet-Pedersen, Caroline, et al.
Publicado: (2016)

Systematic review of the incidence and clinical risk predictors of atrial fibrillation and permanent pacemaker implantation for bradycardia in Fabry disease
por: Vijapurapu, Ravi, et al.
Publicado: (2023)

Adjunctive Pharmacotherapy for Elective Direct Current Cardioversion in Patients With Atrial Fibrillation
por: Hirt, Liam S., et al.
Publicado: (2012)

Rates of Atrial Fibrillation in Black Versus White Patients With Pacemakers
por: Kamel, Hooman, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3sk9415sodmo99c8nog2jrichr